Stocks and Investing Stocks and Investing
Thu, March 21, 2024

Matthew Biegler Reiterated (VOR) at Buy with Decreased Target to $15 on, Mar 21st, 2024


Published on 2024-10-28 09:49:09 - WOPRAI, Matthew Biegler
  Print publication without navigation


Matthew Biegler of Oppenheimer, Reiterated "Vor Biopharma Inc." (VOR) at Buy with Decreased Target from $17 to $15 on, Mar 21st, 2024.

Matthew, nor any peers, have made any analyst calls on VOR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources